1,800 Seconds™ in MS Management: An Online Educational Series for MS Clinicians

MODULE 2: 1,800 Seconds in the Role of Monoclonal Antibodies in MS Treatment

Released On
August 31, 2018

Expires On
August 31, 2019

Media Type
Internet

Completion Time
30 minutes

Specialty
Neurology

Topic(s)
Multiple Sclerosis

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.


Supported by an educational grant from Sanofi Genzyme.

Credit Available

  • Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)
  • Nurses — maximum of 0.5 contact hour(s) (0.5 in the area of pharmacology)
  • Pharmacists — maximum of 0.5 contact hour(s) (.05 CEUS)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

Neurologists, nursing professionals, pharmacists, PAs, rehabilitation specialists, mental health professionals, and other healthcare professionals who manage people with MS within a team-based practice environment.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review the efficacy, safety and tolerability of current and emerging monoclonal antibody MS therapies

Faculty

Mitzi Joi Williams, MD

Neurologist
Multiple Sclerosis Center of Atlanta

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education Credit Designation Statement

The CMSC designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education and will award .5 contact hours (.05 CEUs) to pharmacists who (1) complete the activity, (2) submit a passing posttest, and (3) complete the evaluation form. The Universal Activity Number (UAN) for this activity is JA4008165-9999-18-004-H01-P. This is a knowledge-based activity.

Upon successful completion of the activity, your CE credits will be submitted electronically to the NABP CPE Monitor service. For information about CPE Monitor, visit https://nabp.pharmacy/cpe-monitor-service/

Nursing Continuing Education Credit Designation Statement

The CMSC designates this activity for a maximum of 0.5 contact hours of continuing nursing education (0.5 in the area of pharmacology).

Disclosures of Conflicts of Interest

In accordance with the ACCME Standards for Commercial Support, the Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. CMSC and Catamount Medical Education resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC and Catamount Medical Education seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and Catamount Medical Education are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

The following faculty report that they have relevant financial relationships to disclose:

Mitzi Joi Williams, MD

  • Consulting fees: Biogen Idec, Sanofi-Genzyme, Genentech, TEVA Neuroscience, Novartis
  • Speakers Bureau: Biogen Idec, Sanofi-Genzyme, Genentech, TEVA Neuroscience, Novartis, Mallinckrodt

Activity Staff Disclosures

The planners, reviewers, editors, staff, or other members at CMSC who control content have declared that they have no relevant financial relationships.

The planners, reviewers, editors, staff, CME committee, or other members at Catamount Medical Education who control content have declared that they have no relevant financial relationships.

Method of Participation

(1) There are no fees for participating in and receiving credit for this activity. (2) Review the activity objectives and CME/CE information. (3) Complete the CME/CE activity. (4) Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed. (5) Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs. (6) Credit documentation/reporting: If you are requesting AMA PRA Category 1 Credit(s)™, nursing credit(s) or a certificate of participation—your CME/CE certificate will be available for download.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclosure of Unlabeled Use

CMSC and Catamount Medical Education require CME/CE faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. CMSC and Catamount Medical Education do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

CMSC and Catamount Medical Education present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC and Catamount Medical Education, and the commercial supporters assume no liability for the information herein.

Privacy Policy

Catamount Medical Education, LLC, respects your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CME/CE activities viewed and the post-test and evaluation results for CME/CE credit. This information is provided to activity collaborators for the purposes of CME/CE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information

For each visitor to this Web site, our Web server automatically recognizes information such as the visitor’s IP address. We do not set any cookies on your computer. Catamount Medical Education, LLC, safeguards against the loss, misuse or alteration of information that we have collected in this activity.

Contact Information

If you have questions about this CME/CE activity, please contact Catamount Medical Education at 860-661-4157 or info@catmeded.com.